Translation, Translation, Translation
Over the last 14 days, we have had two scientific meetings taking place right here on the Wellcome Genome Campus, the Translational Bioinformatics conference and the »
Direct versus indirect evidence: should you care?
The latest release of our Open Targets Platform contains 5.1 million pieces of evidence for target-disease associations. Where does this evidence come from? How do »
Open Targets - First Impressions
I recently joined the Open Targets Consortium as Operations Director. This moved me from almost the very end of the R&D pipeline where I »
What do we have in store for you in the run up to Christmas?
The latest release of our Open Targets Platform is out. We have plenty of new web features and new data to help your journey into drug »
An approach to visualising pathway evidence
The starting point in drug discovery is often a specific target or disease. But what if instead you have a specific pathway to start with? As »